Pages that link to "Q33183516"
Jump to navigation
Jump to search
The following pages link to The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service (Q33183516):
Displaying 50 items.
- Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee (Q21092426) (← links)
- Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease (Q24597126) (← links)
- Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease (Q26773485) (← links)
- Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders (Q26779001) (← links)
- Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease? (Q26801733) (← links)
- Parkinsonian syndromes (Q27007524) (← links)
- Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease (Q27686808) (← links)
- Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease (Q28071861) (← links)
- The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort (Q28076121) (← links)
- Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges (Q28235853) (← links)
- Parkinson's disease (Q28264391) (← links)
- Dopamine agonists in Parkinson's disease (Q28276692) (← links)
- Elevated synchrony in Parkinson disease detected with electroencephalography (Q28608374) (← links)
- Validation of the new consensus criteria for the diagnosis of corticobasal degeneration (Q28655239) (← links)
- The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T (Q28660352) (← links)
- Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera (Q28731824) (← links)
- Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease (Q28943440) (← links)
- Parkinson's Disease and Cognitive Impairment (Q30239814) (← links)
- The epidemiology of Parkinson's disease: risk factors and prevention (Q30244421) (← links)
- A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. (Q30531483) (← links)
- Risk prediction for complex diseases: application to Parkinson disease. (Q30540812) (← links)
- Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome (Q30544858) (← links)
- Identification of a novel Parkinson's disease locus via stratified genome-wide association study (Q30571934) (← links)
- The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review (Q30635471) (← links)
- Progressive supranuclear palsy: where are we now? (Q30810295) (← links)
- The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1. (Q30829363) (← links)
- Identification of genetic modifiers of age-at-onset for familial Parkinson's disease (Q30833988) (← links)
- The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans (Q30851659) (← links)
- Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. (Q30982993) (← links)
- Neuroimaging and therapeutics in movement disorders (Q30989947) (← links)
- The diagnosis of Parkinson's disease (Q31026806) (← links)
- Distinguishing Parkinson's disease from atypical parkinsonian syndromes using PET data and a computer system based on support vector machines and Bayesian networks (Q31027199) (← links)
- Free-water imaging in Parkinson's disease and atypical parkinsonism (Q31034031) (← links)
- Automatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson's Disease (Q31095916) (← links)
- Characterization of proteome of human cerebrospinal fluid (Q33245302) (← links)
- The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort (Q33254837) (← links)
- Differential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CT (Q33639396) (← links)
- DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease. (Q33660447) (← links)
- Morbidity in early Parkinson's disease and prior to diagnosis (Q33746827) (← links)
- Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease (Q33754677) (← links)
- Female reproductive factors, menopausal hormone use, and Parkinson's disease (Q33756791) (← links)
- Cutaneous neuropathy in Parkinson's disease: a window into brain pathology (Q33764504) (← links)
- Blood-based biomarkers for Parkinson's disease (Q33804255) (← links)
- Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy (Q33917271) (← links)
- FDG PET in the Evaluation of Parkinson's Disease (Q34035765) (← links)
- Manganese and Parkinson's disease: a critical review and new findings (Q34060040) (← links)
- Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease (Q34066195) (← links)
- Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies (Q34078528) (← links)
- The metabolic brain network in patients with Parkinson's disease based on (18)F-FDG PET imaging: evaluation of neuronal injury and regeneration. (Q34096185) (← links)
- Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study (Q34174901) (← links)